Using data from proprietary technology to enable an AI-Driven surveillance system for bacterial & viral hotspot notification. Accurately predict the next pandemic.

We've developed a cutting-edge system that predicts disease outbreaks in real-time, accelerating the delivery of precise diagnostics and treatments. This rapid response capability can contain the spread of pathogens, minimize the impact of pandemics, and ultimately save lives.

AI-Driven Hot Spot Prediction

Microbe diagnostics using Next Generation Sequencing technology & proprietary portable molecule testing machines

We decode emerging variants with VariantVault, our cutting-edge microbe library, to provide critical insights for effective disease control strategies.

Diagnose first, then treat appropriately and efficiently.

Treatment of drug-resistant microbes with proprietary sterilants, decolonizers and antiviral products

Viropin Pharmaceutical’s proprietary compounds are being formulated as hospital sanitizers, decolonization ointments, pre-surgical scrubs and wound care solutions, which don’t contribute to AMR.

We are also testing novel anti-viral products that would contribute to mitigating influenza A and B and potentially the next viral pandemic.

Threats of drug-resistant bacteria and rapidly-mutating viruses are minimized.